about
Interventions for treatment of herpes simplex labialis (cold sores on the lips)The role of the CoREST/REST repressor complex in herpes simplex virus 1 productive infection and in latencyOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.More common skin infections in childrenHerpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFbHematogenous vertical transmission of herpes simplex virus type 1 in miceReal-time polymerase chain reaction detection of herpes simplex virus in cerebrospinal fluid and cost savings from earlier hospital discharge.Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpesTLR4-MyD88/Mal-NF-kB axis is involved in infection of HSV-2 in human cervical epithelial cells.Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceA forward phenotypically driven unbiased genetic analysis of host genes that moderate herpes simplex virus virulence and stromal keratitis in mice.Acute necrotizing herpetic tonsillitis: a report of two cases.Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilizationRates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells.Herpesviruses in periodontal diseases.Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure.The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.Colloidal dispersions for the delivery of acyclovir: a comparative study.Volatile Acid-Solvent Evaporation (VASE): Molecularly Homogeneous Distribution of Acyclovir in a Bioerodable Polymer Matrix for Long-Term Treatment of Herpes Simplex Virus-1 Infections
P2860
Q24236514-0E24258D-8A5C-4679-8F29-EBB0654373A5Q26823532-705F7893-A5FD-4D52-986B-9024E1E41789Q27021069-00717028-06E8-4410-8C67-950CDDF7E143Q33422983-2217F944-D50A-4F32-818C-253345613525Q33595097-C518F208-34F5-4C65-B56A-DEC8D299F3A2Q33940598-0CF3F8E7-4B5F-444B-9F8A-33EDAB99449BQ34429977-80359A27-0FD9-4EB4-88F2-216EB2DA2426Q34435095-4A24962D-B075-4243-9A57-71B184973414Q34461255-C3813CF3-4F08-46D1-82AC-8F14570E2EB3Q34648207-85A2040A-EB9D-4655-864C-AC9894418182Q35053550-15B8A953-6E66-412F-8879-29A836FEEC26Q35076638-14ED1BFA-2F49-4BAA-875A-D0C3CC2EA566Q35126625-8679B9AA-226D-42C8-8F5A-2D646DA27F2FQ35243915-052E348E-DD72-4272-A1E2-3C7E5C4E7D84Q35785221-7A6EF17C-8281-4C30-967B-3BA3843C1257Q35947667-0F9FC857-E234-48F4-A8C6-C07CBB53C7B0Q36107779-4E439E6C-4307-4BF5-B0FF-135488394C1CQ36746428-3EBE4D38-6086-4FF9-BC89-A3C8D1F119CAQ36747754-AA732EB6-C8C7-46EB-B000-6EC4C153C835Q36938445-4F4C198E-5AF2-44D3-B0D0-010041358786Q37192240-8E529598-48CE-4394-A28B-F02AE2F64BDDQ39769235-BEEE5684-40BD-4316-A81C-5790BE91802BQ40669532-2435AAE3-8922-45C7-B82C-B32C9A9F0C90Q41612313-806DAB15-B26F-4D64-84A8-3BF31033F278Q57821292-802B7656-1E6F-42EA-9E24-B80DD1E19C32
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Herpes simplex virus infection.
@ast
Herpes simplex virus infection.
@en
Herpes simplex virus infection.
@nl
type
label
Herpes simplex virus infection.
@ast
Herpes simplex virus infection.
@en
Herpes simplex virus infection.
@nl
prefLabel
Herpes simplex virus infection.
@ast
Herpes simplex virus infection.
@en
Herpes simplex virus infection.
@nl
P356
P1476
Herpes simplex virus infection.
@en
P2093
Richard J Whitley
P356
10.1053/SPID.2002.29752
P577
2002-01-01T00:00:00Z